Fortress Biotech Inc (NASDAQ:FBIO) — Market Cap & Net Worth
Market Cap & Net Worth: Fortress Biotech Inc (FBIO)
Fortress Biotech Inc (NASDAQ:FBIO) has a market capitalization of $75.03 Million ($75.03 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20304 globally and #4391 in its home market, demonstrating a 4.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fortress Biotech Inc's stock price $2.33 by its total outstanding shares 32202564 (32.20 Million). Analyse FBIO cash generation efficiency to see how efficiently the company converts income to cash.
Fortress Biotech Inc Market Cap History: 2015 to 2026
Fortress Biotech Inc's market capitalization history from 2015 to 2026. Data shows change from $1.35 Billion to $75.03 Million (-24.15% CAGR).
Index Memberships
Fortress Biotech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #578 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1969 of 3165 |
Weight: Fortress Biotech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fortress Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fortress Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.86x
Fortress Biotech Inc's market cap is 1.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.29x
Fortress Biotech Inc's market cap is 17.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.30 Billion | $16.48 Million | -$55.09 Million | 79.14x | N/A |
| 2017 | $1.93 Billion | $187.58 Million | -$66.88 Million | 10.27x | N/A |
| 2018 | $415.41 Million | $26.88 Million | -$84.15 Million | 15.45x | N/A |
| 2019 | $1.24 Billion | $36.63 Million | -$39.96 Million | 33.89x | N/A |
| 2020 | $1.53 Billion | $45.60 Million | -$46.53 Million | 33.58x | N/A |
| 2021 | $1.21 Billion | $68.79 Million | -$64.70 Million | 17.55x | N/A |
| 2022 | $318.81 Million | $75.74 Million | -$86.58 Million | 4.21x | N/A |
| 2023 | $96.93 Million | $84.51 Million | -$60.64 Million | 1.15x | N/A |
| 2024 | $65.21 Million | $57.67 Million | -$46.00 Million | 1.13x | N/A |
| 2025 | $117.86 Million | $63.26 Million | $6.82 Million | 1.86x | 17.29x |
Competitor Companies of FBIO by Market Capitalization
Companies near Fortress Biotech Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Fortress Biotech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Fortress Biotech Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Fortress Biotech Inc's market cap moved from $1.35 Billion to $ 75.03 Million, with a yearly change of -24.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $75.03 Million | -36.34% |
| 2025 | $117.86 Million | +80.74% |
| 2024 | $65.21 Million | -32.72% |
| 2023 | $96.93 Million | -69.60% |
| 2022 | $318.81 Million | -73.60% |
| 2021 | $1.21 Billion | -21.14% |
| 2020 | $1.53 Billion | +23.35% |
| 2019 | $1.24 Billion | +198.84% |
| 2018 | $415.41 Million | -78.45% |
| 2017 | $1.93 Billion | +47.78% |
| 2016 | $1.30 Billion | -3.23% |
| 2015 | $1.35 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Fortress Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.03 Million USD |
| MoneyControl | $75.03 Million USD |
| MarketWatch | $75.03 Million USD |
| marketcap.company | $75.03 Million USD |
| Reuters | $75.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fortress Biotech Inc
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe reca… Read more